Variations of the ApoB, ApoA-I, and ApoB/ApoA-I ratio have been confirmed to exert independent effects on the incidence of higher cardiovascular mortality, type 2 diabetes, stroke, and long-term risk of a major cardiovascular event (28–31). This evidence concerns the gene APOA1 and type 2 diabetes mellitus.